JAGLX : Janus Henderson Global Life Sciences Fund Class T

JAGLX is a Sector Equity Market Healthcare with HIGH fees.

JAGLX

Janus Henderson Global Life Sciences Fund Class T

FI Score

46 /100

Expense Ratio Rating

5 /10

Expense Rating

1 /10

Market Score

9 /10

Category Score

0 /10

Market Size

9 /10

Similar Funds

We found 107 Sector Equity Healthcare funds. Here they are ordered by FI Score.

Compare JAGLX vs SHISX

43% FI Score
  • shisx
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Service Shares

Expenses: 1.15% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs GNOM

43% FI Score
  • gnom
  • ETF
  • Sector Equity
  • Healthcare

Global X Genomics & Biotechnology ETF

Expenses: 0.68% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs SHSAX

43% FI Score
  • shsax
  • Mutual Fund
  • Sector Equity
  • Healthcare

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

Expenses: 1.12% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs FTXH

42% FI Score
  • ftxh
  • ETF
  • Sector Equity
  • Healthcare

First Trust Nasdaq Pharmaceuticals ETF

Expenses: 0.60% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs FSHCX

42% FI Score
  • fshcx
  • Mutual Fund
  • Sector Equity
  • Healthcare

Fidelity® Select Health Care Services Portfolio

Expenses: 0.75% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs BBC

39% FI Score
  • bbc
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Clinical Trials ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs CNCR

39% FI Score
  • cncr
  • ETF
  • Sector Equity
  • Healthcare

Loncar Cancer Immunotherapy ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs FPHAX

38% FI Score
  • fphax
  • Mutual Fund
  • Sector Equity
  • Healthcare

Fidelity® Select Pharmaceuticals Portfolio

Expenses: 0.77% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs BBP

38% FI Score
  • bbp
  • ETF
  • Sector Equity
  • Healthcare

Virtus LifeSci Biotech Products ETF

Expenses: 0.79% (Better than 1% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Compare JAGLX vs HGHVX

37% FI Score
  • hghvx
  • Mutual Fund
  • Sector Equity
  • Healthcare

The Hartford Healthcare Fund Class R6

Expenses: 0.91% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »

Minafi - The intersection of FI, minimalism & mindfulness.

Don't miss out on new posts, courses, interactive articles and more!

Join & Get Your First Course Free

© 2024   Adam Fortuna

Site Map
Triangle Graduation Cap Angle Down Book regular Phone laptop regular fire regular fire regular search regular Acorn duotone Seedling duotone thumbs down duo thumbs up duo